We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Dublin-based investor in life sciences companies - Reports intrinsic equity value of EUR6.44 at June 30 half-year end, ...
Dublin-based investor in life sciences companies - Investee company Poseida Therapeutics Inc enters into a research co ...
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Dublin-based investor in life sciences companies - Confirms that Fiona Dunlevy joins the board as an executive directo ...
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...
Malin Corp PLC said that its Chief Executive Officer Darragh Lyons will resign from his position before the end of 20 ...
Amended the initial Purchase Agreement to effectuate the first step of the transaction Transaction expected to officially close in the third quarter of 2023 TORONTO, May 02, 2023 (GLOBE...
Increased Total Revenue in both the Asset Management and Insurance Segments, Increased Fee Related Earnings, Signed an Agreement for an Additional Acquisition following Year-End 2022 Declares...
Malin Corp PLC on Tuesday said it will return EUR140 million to shareholders, through a tender offer. In February, t ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions